338 related articles for article (PubMed ID: 15971369)
1. Genomic capital: public cultures and market logics of corporate biotechnology.
Rajan KS
Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369
[No Abstract] [Full Text] [Related]
2. The times they are a-changin'.
Patrinos A; Drell D
Nature; 2002 Jun; 417(6889):589-90. PubMed ID: 12050635
[No Abstract] [Full Text] [Related]
3. The Human Genome Project: a public good.
Hudson K
Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
[No Abstract] [Full Text] [Related]
4. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
5. Should we patent God's creation?
Peters T
Dialog; 1996; 35(2):117-32. PubMed ID: 11660577
[No Abstract] [Full Text] [Related]
6. In pursuit of patents: 21st century challenges.
Blatt RJ
J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745
[No Abstract] [Full Text] [Related]
7. The price of profit.
Coghlan A
New Sci; 1998 May; 158(2134):20-1. PubMed ID: 11660513
[No Abstract] [Full Text] [Related]
8. Squabbling all the way to the genebank.
Kleiner K
New Sci; 1994 Nov; 144(1953):14-5. PubMed ID: 11656411
[No Abstract] [Full Text] [Related]
9. Who owns the genome?
Angrist M; Cook-Deegan RM
New Atlantis; 2006; 11():87-96. PubMed ID: 16789312
[No Abstract] [Full Text] [Related]
10. Human chromosome 22 and the virtues of collaboration.
Nature; 1999 Dec; 402(6761):445. PubMed ID: 10591189
[No Abstract] [Full Text] [Related]
11. In the crossfire: Collins on genomes, patents, and 'rivalry'. Interview by Eliot Marshall, Elizabeth Pennisi, and Leslie Roberts.
Collins F
Science; 2000 Mar; 287(5462):2396-8. PubMed ID: 10766612
[No Abstract] [Full Text] [Related]
12. Celera turns to public genome data to speed up endgame.
Smaglik P; Butler D
Nature; 2000 Jan; 403(6766):119. PubMed ID: 10646565
[No Abstract] [Full Text] [Related]
13. The Human Genome Project: lessons from large-scale biology.
Collins FS; Morgan M; Patrinos A
Science; 2003 Apr; 300(5617):286-90. PubMed ID: 12690187
[No Abstract] [Full Text] [Related]
14. Big bucks buy up genome secrets.
Coghlan A
New Sci; 1995 Sep; 147(1997):4. PubMed ID: 11656461
[No Abstract] [Full Text] [Related]
15. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
16. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
Caulfield T
Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021
[No Abstract] [Full Text] [Related]
17. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
18. Genome sequencing. Talks of public-private deal end in acrimony.
Marshall E
Science; 2000 Mar; 287(5459):1723-5. PubMed ID: 10755918
[No Abstract] [Full Text] [Related]
19. Relations thaw between genome rivals as finish line draws near.
Smaglik P
Nature; 2000 Jun; 405(6788):721. PubMed ID: 10866160
[No Abstract] [Full Text] [Related]
20. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
